Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Cancer immunotherapy: breaking the barriers to harvest the crop

Successful translation of modern molecular immunology into effective cancer immunotherapy is threatened by regulatory barriers and challenges to the development of novel agents and combinatorial strategies through effective public-private partnerships. For its promise to be fully realized, both the National Cancer Institute and Food and Drug Administration must take active steps to help academic investigators and companies jointly navigate the pathways from laboratory to clinic.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Multiple points of intervention to engender successful cancer immunotherapy.
Figure 2: Potential pathways by which the NCI and FCA could facilitate the development of combinatorial immunotherapies.

References

  1. Slamon, D.J. et al. N. Engl. J. Med. 344, 783–792 (2001).

    Article  CAS  Google Scholar 

  2. Akhtar, S. & Maghfoor, I. N. Engl. J. Med. 346, 1830–1831 (2002).

    Article  Google Scholar 

  3. Winter, G. & Harris, W.J. Trends Pharmacol. Sci. 14, 139–143 (2003).

    Article  Google Scholar 

  4. Willett, C.G. et al. Nat Med. 10, 145–147 (2004).

    Article  CAS  Google Scholar 

  5. Waldmann, H. Med. Oncol. 19 (Suppl.), S3–S9 (2002).

    Article  Google Scholar 

  6. Hersey, P. Intern. Med. J. 33, 33–43 (2003).

    Article  CAS  Google Scholar 

  7. Yee, C. et al. Proc. Natl. Acad. Sci. USA 99, 16168–16173 (2002).

    Article  CAS  Google Scholar 

  8. Dudley, M.E. et al. Science 298, 850–854 (2002).

    Article  CAS  Google Scholar 

  9. Pardoll, D.M. Nat. Rev. Immunol. 2, 227–238 (2002).

    Article  CAS  Google Scholar 

  10. Blattman, J.N. & Greenberg, P.D. Science 305, 200–205 (2004).

    Article  CAS  Google Scholar 

  11. Levitsky, H.I. Cancer J. 6 (Suppl.), S281–S290 (2000).

    PubMed  Google Scholar 

  12. Pardoll, D. Annu. Rev. Immunol. 21, 807–839 (2003).

    Article  CAS  Google Scholar 

  13. Chambers, C.A., Kuhns, M.S., Egen, J.G. & Allison, J.P. Annu. Rev. Immunol. 19, 565–594 (2001).

    Article  CAS  Google Scholar 

  14. Dong, H. et al. Nat. Med. 8, 793–800 (2002).

    Article  CAS  Google Scholar 

  15. Sutmuller, R.P. et al. J. Exp. Med. 194, 823–832 (2001).

    Article  CAS  Google Scholar 

  16. Phan, G.Q. et al. Proc. Natl. Acad. Sci. USA 100, 8372–8377 (2003).

    Article  CAS  Google Scholar 

  17. Stolberg, S.G. New York Times Magazine 28 Nov (1999) pp. 136–140, 149–150.

    Google Scholar 

  18. Smith, L. & Byers, J.F. JONAS Healthc Law Ethics Regul. 4, 104–110 (2002).

    Article  Google Scholar 

  19. Grilley, B.J. & Gee, A.P. Cytotherapy 5, 197–207 (2003).

    Article  CAS  Google Scholar 

  20. Ergenzinger, E. & Spruill, M. Scientist 17, 43 (2003).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pardoll, D., Allison, J. Cancer immunotherapy: breaking the barriers to harvest the crop. Nat Med 10, 887–892 (2004). https://doi.org/10.1038/nm0904-887

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0904-887

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing